Latest Ratios: P/E Ratio -6.1x · EV/EBITDA 52.9x · ROE -14.1%. (2002–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $672M | $508M | $1.1B | $1.1B | $1.1B | $1.7B | $1.7B | $1.6B | $1.3B | $3.0B | $1.4B |
| Enterprise Value | $1.2B | $1.0B | $1.5B | $1.4B | $1.2B | $1.8B | $1.9B | $1.6B | $1.4B | $3.1B | $1.7B |
| P/E Ratio → | -6.08 | — | 13.00 | — | 10.44 | 15.32 | 27.11 | 17.87 | 6.51 | 8.42 | 32.27 |
| P/S Ratio | 0.36 | 0.27 | 0.59 | 0.69 | 0.56 | 0.89 | 1.05 | 0.90 | 0.80 | 1.73 | 1.01 |
| P/B Ratio | 0.89 | 0.68 | 1.37 | 1.42 | 1.13 | 1.99 | 2.16 | 1.90 | 1.59 | 3.96 | 3.50 |
| P/FCF | — | — | 26.08 | — | 58.69 | 11.72 | 43.42 | 14.75 | 10.10 | 14.10 | 37.81 |
| P/OCF | 268.76 | 203.32 | 15.47 | 208.02 | 13.29 | 8.40 | 16.82 | 9.68 | 7.08 | 10.82 | 15.44 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.56 | 0.82 | 0.85 | 0.62 | 0.93 | 1.15 | 0.94 | 0.85 | 1.82 | 1.23 |
| EV / EBITDA | 52.93 | 45.79 | 8.24 | — | 5.58 | 7.34 | 10.40 | 8.15 | 3.73 | 8.45 | 13.75 |
| EV / EBIT | — | — | 8.01 | — | 7.99 | 10.40 | 19.00 | 11.69 | 4.65 | 9.67 | 23.35 |
| EV / FCF | — | — | 35.87 | — | 65.10 | 12.16 | 47.39 | 15.54 | 10.73 | 14.82 | 45.69 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 11.5% | 11.5% | 19.0% | 9.9% | 20.3% | 23.0% | 21.4% | 22.3% | 33.8% | 32.3% | 18.8% |
| Operating Margin | -2.3% | -2.3% | 6.5% | -3.4% | 8.3% | 9.6% | 7.1% | 8.4% | 19.9% | 19.1% | 5.9% |
| Net Profit Margin | -6.0% | -6.0% | 4.6% | -2.9% | 5.4% | 5.8% | 3.9% | 5.0% | 12.3% | 20.5% | 3.2% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -14.1% | -14.1% | 10.6% | -5.6% | 11.4% | 13.5% | 7.9% | 10.5% | 25.7% | 61.7% | 10.1% |
| ROA | -5.9% | -5.9% | 4.6% | -2.6% | 5.3% | 5.6% | 3.2% | 4.5% | 11.0% | 23.6% | 3.6% |
| ROIC | -2.5% | -2.5% | 8.0% | -3.9% | 11.9% | 14.9% | 9.4% | 12.0% | 27.1% | 31.2% | 8.7% |
| ROCE | -2.9% | -2.9% | 8.5% | -3.6% | 9.6% | 10.7% | 6.7% | 8.7% | 20.3% | 25.5% | 8.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.77 | 0.77 | 0.65 | 0.57 | 0.47 | 0.54 | 0.64 | 0.58 | 0.54 | 0.63 | 0.86 |
| Debt / EBITDA | 25.21 | 25.21 | 2.82 | — | 2.07 | 1.92 | 2.84 | 2.36 | 1.20 | 1.28 | 2.79 |
| Net Debt / Equity | — | 0.72 | 0.52 | 0.33 | 0.12 | 0.07 | 0.20 | 0.10 | 0.10 | 0.20 | 0.73 |
| Net Debt / EBITDA | 23.59 | 23.59 | 2.25 | — | 0.55 | 0.26 | 0.87 | 0.41 | 0.22 | 0.41 | 2.37 |
| Debt / FCF | — | — | 9.80 | — | 6.41 | 0.44 | 3.97 | 0.79 | 0.63 | 0.72 | 7.88 |
| Interest Coverage | -0.84 | -0.84 | 4.49 | -3.26 | 8.92 | 8.83 | 5.21 | 7.48 | 15.65 | 17.09 | 3.49 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.70 | 2.70 | 2.32 | 3.01 | 3.80 | 4.36 | 4.68 | 4.51 | 5.15 | 4.59 | 3.57 |
| Quick Ratio | 2.70 | 2.70 | 0.94 | 1.49 | 1.94 | 2.86 | 2.69 | 2.65 | 3.01 | 2.94 | 1.69 |
| Cash Ratio | 0.10 | 0.10 | 0.22 | 0.53 | 1.00 | 1.41 | 1.37 | 1.44 | 1.60 | 1.39 | 0.28 |
| Asset Turnover | — | 1.02 | 0.99 | 0.91 | 1.00 | 0.96 | 0.80 | 0.88 | 0.88 | 0.95 | 1.16 |
| Inventory Turnover | — | — | 2.33 | 2.66 | 2.53 | 3.45 | 2.48 | 2.67 | 2.21 | 3.06 | 3.22 |
| Days Sales Outstanding | — | 56.50 | 56.40 | 68.44 | 48.24 | 71.35 | 71.94 | 65.24 | 68.63 | 73.15 | 65.44 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.4% | 4.5% | 4.9% | 7.6% | 8.1% | 4.8% | 4.8% | 5.4% | 5.9% | 2.3% | 5.0% |
| Payout Ratio | — | — | 64.0% | — | 84.0% | 73.7% | 130.2% | 95.8% | 38.4% | 19.6% | 160.5% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 7.7% | — | 9.6% | 6.5% | 3.7% | 5.6% | 15.4% | 11.9% | 3.1% |
| FCF Yield | — | — | 3.8% | — | 1.7% | 8.5% | 2.3% | 6.8% | 9.9% | 7.1% | 2.6% |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.3% | 0.2% | 0.0% | 0.1% | 0.2% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 3.4% | 4.5% | 4.9% | 7.9% | 8.3% | 4.8% | 4.9% | 5.6% | 5.9% | 2.3% | 5.0% |
| Shares Outstanding | — | $115M | $115M | $115M | $116M | $116M | $116M | $116M | $116M | $116M | $116M |
European energy cost volatility
As reported in recent financial filings, KRO's negative TTM P/E of -6.80 and elevated EV/EBITDA of 56.40 suggest that current market pricing is heavily influenced by depressed earnings rather than long-term growth potential, warranting caution for investors seeking traditional valuation anchors in this highly cyclical chemical producer.
The current valuation multiples appear to be heavily distorted by the company's recent inability to generate consistent operating income. Investors should note that the forward EV/EBITDA of 8.78 implies a market expectation of a significant earnings recovery, which may be overly optimistic given the structural headwinds facing the firm's European manufacturing base.
Based on the company's reported figures, ROIC has fluctuated from a peak of 2.5% in 2024Q2 to a negative 3.6% in 2025Q4, indicating that the firm is currently failing to generate returns that exceed its cost of capital, a trend that suggests significant value destruction during this cycle.
The inability to maintain positive ROIC highlights the difficulty of managing a high fixed-cost base in a period of stagnant volume growth. This trend suggests that the company's capital allocation strategy may be struggling to adapt to the current margin environment, potentially necessitating a re-evaluation of long-term asset productivity.
According to quarterly data, the cash conversion cycle has remained volatile, reaching as high as 183 days in 2024Q4, which reflects the company's ongoing struggle to optimize inventory levels and manage receivables effectively within its complex global distribution network and European-centric supply chain operations.
The extended CCC suggests that the company is tying up significant liquidity in working capital, which exacerbates the pressure on its already strained cash position. Investors should monitor whether management can reduce these cycles, as any further expansion in DIO or DSO could signal deeper operational inefficiencies in inventory management.
As reported in recent financial statements, the current ratio has fluctuated significantly, yet the rapid depletion of cash reserves to $28.2 million in 2026Q1 indicates a narrowing margin of safety that leaves the company increasingly vulnerable to unexpected operational shocks or further downturns in pigment pricing.
While the current ratio of 3.18 might appear superficially healthy, the composition of current assets—heavily weighted toward inventory—suggests that liquidity is not as robust as the headline number implies. This reliance on inventory liquidity warrants further investigation, as it may be difficult to convert these assets to cash quickly during a sector-wide demand slump.
The P/E ratio is frequently misapplied to KRO, as the company's high fixed-cost structure and cyclical earnings volatility render trailing earnings metrics largely meaningless for assessing the firm's true underlying earning power or its ability to navigate the current downturn in the global TiO2 market.
Investors should instead focus on EV/EBITDA or price-to-book metrics, which better account for the company's capital-intensive nature and debt-heavy balance sheet. Relying on P/E in this context risks ignoring the significant impact of non-recurring items and the cyclical nature of the chemical industry, which often leads to misleading conclusions about the company's valuation.
Includes 30+ ratios · 24 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying KRO stock.
Kronos Worldwide, Inc.'s current P/E ratio is -6.1x. The historical average is 17.8x.
Kronos Worldwide, Inc.'s current EV/EBITDA is 52.9x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 13.0x.
Kronos Worldwide, Inc.'s return on equity (ROE) is -14.1%. The historical average is 14.9%.
Based on historical data, Kronos Worldwide, Inc. is trading at a P/E of -6.1x. Compare with industry peers and growth rates for a complete picture.
Kronos Worldwide, Inc.'s current dividend yield is 3.42%.
Kronos Worldwide, Inc. has 11.5% gross margin and -2.3% operating margin.
Kronos Worldwide, Inc.'s Debt/EBITDA ratio is 25.2x, indicating high leverage. A ratio above 4x may signal elevated financial risk.